Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents the growing number of participants diagnosed with melanoma in the UK each year and the need for new therapeutic approaches to improve treatment outcomes.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:56.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria'. This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    33%
    Check dated 2024-05-22T21:14:50.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:24:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.